127 related articles for article (PubMed ID: 38525011)
1. Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect.
Huang X; Chen Y; Zhong F; Gui B; Hu Y; Guo Y; Deng Q; Zhou Q
Int J Nanomedicine; 2024; 19():2793-2806. PubMed ID: 38525011
[TBL] [Abstract][Full Text] [Related]
2. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
[TBL] [Abstract][Full Text] [Related]
3. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
4. Nanobubble-based anti-hepatocellular carcinoma therapy combining immune check inhibitors and sonodynamic therapy.
Liu Y; Yang S; Zhou Q; Zhou J; Li J; Ma Y; Hu B; Liu C; Zhao Y
Nanoscale Adv; 2022 Nov; 4(22):4847-4862. PubMed ID: 36545394
[TBL] [Abstract][Full Text] [Related]
5. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
[TBL] [Abstract][Full Text] [Related]
6. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
[TBL] [Abstract][Full Text] [Related]
7. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
[TBL] [Abstract][Full Text] [Related]
8. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
10. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes.
Wang D; Wan Z; Yang Q; Chen J; Liu Y; Lu F; Tang J
Drug Deliv; 2022 Dec; 29(1):702-713. PubMed ID: 35236203
[TBL] [Abstract][Full Text] [Related]
11. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
12. Chlorin e6-associated photodynamic therapy enhances abscopal antitumor effects via inhibition of PD-1/PD-L1 immune checkpoint.
Gurung P; Lim J; Shrestha R; Kim YW
Sci Rep; 2023 Mar; 13(1):4647. PubMed ID: 36944686
[TBL] [Abstract][Full Text] [Related]
13. A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy.
Jiang Q; Qiao B; Lin X; Cao J; Zhang N; Guo H; Liu W; Zhu L; Xie X; Wan L; Tang R; Liang B; Wang D; Wang Z; Zhou Y; Ran H; Li P
Theranostics; 2022; 12(1):59-75. PubMed ID: 34987634
[TBL] [Abstract][Full Text] [Related]
14. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
[TBL] [Abstract][Full Text] [Related]
15. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
16. Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy.
Li W; Zhang Z; Liu J; Wang B; Pu G; Li J; Huang Y; Chu M
Acta Biomater; 2022 Jul; 146():341-356. PubMed ID: 35580829
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice.
Shi H; Liu Q; Qin X; Wang P; Wang X
Biopharm Drug Dispos; 2011 Sep; 32(6):319-32. PubMed ID: 21815170
[TBL] [Abstract][Full Text] [Related]
18. Chlorin e6-loaded sonosensitive magnetic nanoliposomes conjugated with the magnetic field for enhancing anti-tumor effect of sonodynamic therapy.
Zhu HM; He Y; Huang SS; Tian JJ; Wang LS; Hao JD; Xie B; Ling JJ
Pharm Dev Technol; 2020 Dec; 25(10):1249-1259. PubMed ID: 32811263
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy.
Nguyen Cao TG; Truong Hoang Q; Hong EJ; Kang SJ; Kang JH; Ravichandran V; Kang HC; Ko YT; Rhee WJ; Shim MS
J Control Release; 2023 Feb; 354():651-663. PubMed ID: 36682729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
